Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
https://doi.org/10.18632/oncotarget.25764
Lilla Ozgyin,
Attila Horvath,
and Balint Laszlo Balint
|
31312-31329 |
Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process
Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process |
https://doi.org/10.18632/oncotarget.25808
Susana Bulnes,
Garazi Bermúdez,
and José Vicente Lafuente
|
31330-31341 |
A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells
A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells |
https://doi.org/10.18632/oncotarget.25809
Mamiko Kobayashi,
Daisuke Mikami,
Junsuke Uwada,
Takashi Yazawa,
Kazuko Kamiyama,
Hideki Kimura,
Takanobu Taniguchi,
and Masayuki Iwano
|
31342-31354 |
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis |
https://doi.org/10.18632/oncotarget.25823
Roberta Fusco,
Ramona D’amico,
Marika Cordaro,
Enrico Gugliandolo,
Rosalba Siracusa,
Alessio Filippo Peritore,
Rosalia Crupi,
Daniela Impellizzeri,
Salvatore Cuzzocrea,
and Rosanna Di Paola
|
31355-31366 |
STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models
STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models |
https://doi.org/10.18632/oncotarget.25825
Gabriela Rozic,
Lena Paukov,
Ziv Cohen,
Irit Shapira,
Adrian Duek,
Ohad Bejamini,
Abraham Avigdor,
Arnon Nagler,
Igor Koman,
and Merav Leiba
|
31367-31379 |
Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3
Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3 |
https://doi.org/10.18632/oncotarget.25826
Giulia Marelli,
Roberta Avigni,
Paola Allavena,
Cecilia Garlanda,
Alberto Mantovani,
Andrea Doni,
and Marco Erreni
|
31380-31396 |
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma |
https://doi.org/10.18632/oncotarget.25829
Daniel Jose García-Domínguez,
Lourdes Hontecillas-Prieto,
Pablo Rodríguez-Núñez,
Guillem Pascual-Pasto,
Monica Vila-Ubach,
Rosa García-Mejías,
María José Robles,
Oscar M. Tirado,
Jaume Mora,
Angel M. Carcaboso,
and Enrique de Álava
|
31397-31410 |
Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies
Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies |
https://doi.org/10.18632/oncotarget.25830
Toshiki Iwai,
Masamichi Sugimoto,
Daiko Wakita,
Keigo Yorozu,
Mitsue Kurasawa,
and Kaname Yamamoto
|
31411-31421 |
Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo
Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo |
https://doi.org/10.18632/oncotarget.25831
Yuya Isoda,
Wen Piao,
Eri Taguchi,
Junko Iwano,
Shigeki Takaoka,
Aiko Uchida,
Kiyomi Yoshikawa,
Junichi Enokizono,
Emi Arakawa,
Kazuma Tomizuka,
Yasuhisa Shiraishi,
and Kazuhiro Masuda
|
31422-31431 |
CCL17/TARC and CCR4 expression in Merkel cell carcinoma
CCL17/TARC and CCR4 expression in Merkel cell carcinoma |
https://doi.org/10.18632/oncotarget.25836
Kashif Rasheed,
Ibrahim Abdulsalam,
Silje Fismen,
Øystein Grimstad,
Baldur Sveinbjørnsson,
and Ugo Moens
|
31432-31447 |
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer |
https://doi.org/10.18632/oncotarget.25837
Mariko Tsukagoshi,
Satoshi Wada,
Seiko Hirono,
Shintaro Yoshida,
Erica Yada,
Tetsuro Sasada,
Ken Shirabe,
Hiroyuki Kuwano,
and Hiroki Yamaue
|
31448-31458 |
High AGR2 protein is a feature of low grade endometrial cancer cells
High AGR2 protein is a feature of low grade endometrial cancer cells |
https://doi.org/10.18632/oncotarget.25838
Areege Kamal,
Anthony Valentijn,
Roger Barraclough,
Philip Rudland,
Nihad Rahmatalla,
Pierre Martin-Hirsch,
Helen Stringfellow,
Shandya B. Decruze,
and Dharani K. Hapangama
|
31459-31472 |
Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma
Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma |
https://doi.org/10.18632/oncotarget.25843
Kheshwant S. Gill,
Philana Fernandes,
Brian Bird,
Declan M. Soden,
and Patrick F. Forde
|
31473-31489 |
Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T
Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T |
https://doi.org/10.18632/oncotarget.25844
Jonathan Klein,
Wilfred W. Lam,
Gregory J. Czarnota,
and Greg J. Stanisz
|
31490-31501 |
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content |
https://doi.org/10.18632/oncotarget.25845
Tessa P. Sandberg,
Jan Oosting,
Gabi W. van Pelt,
Wilma E. Mesker,
Rob A.E.M. Tollenaar,
and Hans Morreau
|
31502-31515 |
Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer
Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer |
https://doi.org/10.18632/oncotarget.25846
Phuong Thao Nguyen,
Dung Nguyen,
Chanbora Chea,
Mutsumi Miyauchi,
Makiko Fujii,
and Takashi Takata
|
31516-31530 |
The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation
The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation |
https://doi.org/10.18632/oncotarget.25847
Taiane Schneider,
Arturo Martinez-Martinez,
Monica Cubillos-Rojas,
Ramon Bartrons,
Francesc Ventura,
and Jose Luis Rosa
|
31531-31548 |
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells |
https://doi.org/10.18632/oncotarget.25862
Pol Gimenez-Xavier,
Eva Pros,
Ana Aza,
Sebastian Moran,
Raul Tonda,
Anna Esteve-Codina,
Marc Dabad,
and Montse Sanchez-Cespedes
|
31549-31558 |
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB |
https://doi.org/10.18632/oncotarget.25943
Po-Hao Feng,
Chih-Teng Yu,
Kuan-Yuan Chen,
Ching-Shan Luo,
Shen Ming Wu,
Chien-Ying Liu,
Lu Wei Kuo,
Yao-Fei Chan,
Tzu-Tao Chen,
Chih-Cheng Chang,
Chun-Nin Lee,
Hsiao-Chi Chuang,
Chiou-Feng Lin,
Chia-Li Han,
Wei-Hwa Lee,
and Kang-Yun Lee
|
31559-31559 |